Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10

Jixian Wang, Luokun Xie, Chenqi Yang, Chang­hong Ren, Kaijing Zhou, Brian Wang, Zhijun Zhang, Yongting Wang, Kunlin Jin, Guo-Yuan YangFrontiers in Cellular Neuroscience 2015 · DOI

Abstract

Recent studies have demonstrated that the depletion of Regulatory T cells (Tregs) inhibits neural progenitor cell migration after brain ischemia. However, whether Tregs affect neural stem/progenitor cell proliferation is unclear. We explored the effect of Tregs on neurogenesis in the subventricular zone (SVZ) after ischemia. Tregs were isolated and activated in vitro. Adult male C57BL/6 mice underwent 60 min transient middle cerebral artery occlusion (tMCAO). Then Tregs (1 × 10⁵) were injected into the left lateral ventricle (LV) of normal and ischemic mouse brain. Neurogenesis was determined by immunostaining. The mechanism was examined by inhibiting interleukin 10 (IL-10) and transforming growth factor (TGF-β) signaling. We found that the number of BrdU(+) cells in the SVZ was significantly increased in the activated Tregs-treated mice. Double immunostaining showed that these BrdU(+) cells expressed Mash1. Blocking IL-10 reduced the number of Mash1(+)/BrdU(+) cells, but increased the amount of GFAP(+)/BrdU(+) cells. Here, we conclude that activated Tregs enhanced neural stem cell (NSC) proliferation in the SVZ of normal and ischemic mice; blockage of IL-10 abolished Tregs-mediated NSC proliferation in vivo and in vitro. Our results suggest that activated Tregs promoted NSC proliferation via IL-10, which provides a new therapeutic approach for ischemic stroke.

Introduction

Ischemic stroke causes massive neuronal death and often leads to irreversible functional deficits. While the adult mammalian brain has a limited capacity for self-repair through neurogenesis in regions like the subventricular zone (SVZ), this natural response is typically insufficient for recovery.

Previous research established that Regulatory T cells (Tregs)—the immune system's "peacekeepers"—help limit post-stroke inflammation and assist in the migration of neural progenitor cells. However, it remained unclear whether Tregs could directly stimulate these stem cells to multiply. This study investigates whether Tregs influence neural stem cell (NSC) proliferation and identifies the molecular signaling pathways involved in this neuro-immune crosstalk.

Methods

The researchers employed a combination of in vivo mouse models and in vitro cell cultures:

  • Stroke Model: Transient middle cerebral artery occlusion (tMCAO) was performed on adult C57BL/6 mice to simulate ischemic stroke.
  • Treg Activation: Tregs were isolated from mouse spleens and activated in vitro using CD3e/CD28 antibodies and Interleukin-2 to mimic an active immune response.
  • Cell Delivery: 100,000 activated Tregs were injected directly into the lateral ventricle to target the SVZ niche.
  • Tracking Proliferation: BrdU (a synthetic nucleoside) was used to label dividing cells. Specific cell types were identified via immunostaining for Mash1 (transit-amplifying cells), GFAP (glial cells), and DCX (immature neurons).
  • Mechanism Blocking: Neutralizing antibodies were used to block IL-10 and TGF-β signaling to determine which cytokine mediated the proliferative effect.

Key Insights and Results

Activation and Cytokine Profile

A critical finding was that resting (un-stimulated) Tregs had no effect on stem cell proliferation. Only activated Tregs (A-Tregs) stimulated the SVZ. Analysis revealed that A-Tregs express significantly higher levels of IL-10 compared to un-activated controls, while levels of other anti-inflammatory cytokines like TGF-β and ebi3 remained relatively stable.

Characterization of activated Tregs (A-Tregs) showing increased Foxp3 expression, activation markers (CD44 high, CD62L low), and significant upregulation of IL-10 compared to un-activated controls.

IL-10 as the Master Regulator

While both IL-10 and TGF-β are classic anti-inflammatory signals, only blocking IL-10 abolished the neurogenic effect. In both normal and ischemic brains, A-Treg treatment significantly increased the number of BrdU+ cells in the SVZ. Specifically, A-Tregs boosted the proportion of Mash1+ (pro-neuronal) progenitor cells. Interestingly, when IL-10 was blocked, the number of Mash1+ cells dropped while GFAP+ (glial-like) cells increased, suggesting that IL-10 helps steer stem cells toward a neuronal lineage rather than a glial fate.

In Vitro Validation

Co-culturing NSCs with A-Tregs increased both the number and diameter of neurospheres. This effect was completely reversed by the addition of an IL-10 blocker, confirming the cytokine's direct role in promoting NSC proliferation.

Discussion and Conclusion

This study identifies a novel role for activated Tregs in promoting neurogenesis via IL-10 signaling. By specifically targeting Mash1+ transit-amplifying cells, Tregs enhance the brain's regenerative potential following ischemic injury.

However, the study is limited by its short three-day observation window, which is insufficient to determine if these new cells survive and integrate into functional circuits. Furthermore, the invasive nature of direct ventricular injection suggests that future research should explore systemic delivery methods or IL-10-mimicking pharmacological agents. Despite these limitations, the findings provide a promising immunotherapeutic target for enhancing brain repair after stroke.

Summary updated

Abstract

Recent studies have demonstrated that the depletion of Regulatory T cells (Tregs) inhibits neural progenitor cell migration after brain ischemia. However, whether Tregs affect neural stem/progenitor cell proliferation is unclear. We explored the effect of Tregs on neurogenesis in the subventricular zone (SVZ) after ischemia. Tregs were isolated and activated in vitro. Adult male C57BL/6 mice underwent 60 min transient middle cerebral artery occlusion (tMCAO). Then Tregs (1 × 10(5)) were injected into the left lateral ventricle (LV) of normal and ischemic mouse brain. Neurogenesis was determined by immunostaining. The mechanism was examined by inhibiting interleukin 10 (IL-10) and transforming growth factor (TGF-β) signaling. We found that the number of BrdU(+) cells in the SVZ was significantly increased in the activated Tregs-treated mice. Double immunostaining showed that these BrdU(+) cells expressed Mash1. Blocking IL-10 reduced the number of Mash1(+)/BrdU(+) cells, but increased the amount of GFAP(+)/BrdU(+) cells. Here, we conclude that activated Tregs enhanced neural stem cell (NSC) proliferation in the SVZ of normal and ischemic mice; blockage of IL-10 abolished Tregs-mediated NSC proliferation in vivo and in vitro. Our results suggest that activated Tregs promoted NSC proliferation via IL-10, which provides a new therapeutic approach for ischemic stroke.
BibTeX
@inproceedings{wang2015activated,
  author = {Jixian Wang and Luokun Xie and Chenqi Yang and Chang­hong Ren and Kaijing Zhou and Brian Wang and Zhijun Zhang and Yongting Wang and Kunlin Jin and Guo-Yuan Yang},
  title = {{Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10}},
  booktitle = {Frontiers in Cellular Neuroscience},
  year = {2015},
  doi = {10.3389/fncel.2015.00361},
}
Figure